FILED AND SPONSOR-REPORTED ETF HOLDINGS
CGEM Included in ETFs
Dates are first observed in retained official snapshots; “baseline” means the security was already present in the earliest retained snapshot and is not an invented original addition date.
Current ETFs holding CGEM
6 latest ETF portfolios currently report this security.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 0.809296% | 2026-01-30 (baseline) | 2026-04-30 |
| CANC | Tema Oncology ETF | 0.456291% | 2025-11-30 (baseline) | 2026-02-28 |
| OPTZ | Optimize Strategy Index ETF | 0.191884% | 2026-03-31 | 2026-03-31 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.188093% | 2026-04-30 (baseline) | 2026-04-30 |
| GSSC | Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | 0.035287% | 2025-11-30 (baseline) | 2026-02-28 |
| IWV | iShares Russell 3000 ETF | 0.001396% | 2025-12-31 (baseline) | 2026-03-31 |
Previous ETFs holding CGEM
No previous ETF membership has been observed within the retained snapshot history.